CNTB (STOCKS)
Connect Biopharma Holdings Limited Ordinary Shares
$2.060000
-0.060000 (-2.83%)
Prev close: $2.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Barry D. Quart
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $130.02M
- Employees
- 62
- P/E (TTM)
- -1.79
- P/B (TTM)
- 3.03
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-2.35 | $-1.54 | -0.8159 | -53.05% |
|
Dec 2025 (Q4)
|
$-1.91 | $-1.44 | -0.4712 | -32.66% |
|
Sep 2025 (Q3)
|
$-0.31 | $-1.01 | +0.7040 | +69.43% |
|
Jun 2025 (Q2)
|
$-0.23 | $-0.92 | +0.6892 | +74.98% |
Financial Statements
| Revenues | $233.00K |
| Nonoperating Income/Loss | $1.82M |
| Operating Expenses | $66.47M |
| Research and Development | $46.20M |
| Other Operating Expenses | $20.27M |
| Operating Income/Loss | -$66.23M |
| Income/Loss From Continuing Operations After Tax | -$64.61M |
| Income/Loss From Continuing Operations Before Tax | -$64.47M |
| Income Tax Expense/Benefit | $191.00K |
| Net Income/Loss | -$64.61M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$64.61M |
| Net Income/Loss Available To Common Stockholders, Basic | -$64.61M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.15 |
| Diluted Earnings Per Share | -$1.15 |
| Basic Average Shares | 56,853,000 |
| Diluted Average Shares | 56,853,000 |
| Assets | $60.07M |
| Current Assets | $55.02M |
| Prepaid Expenses | $5.52M |
| Other Current Assets | $49.50M |
| Noncurrent Assets | $5.05M |
| Fixed Assets | $3.70M |
| Other Non-current Assets | $1.34M |
| Liabilities | $17.44M |
| Current Liabilities | $17.05M |
| Accounts Payable | $4.31M |
| Wages | $1.42M |
| Other Current Liabilities | $11.32M |
| Noncurrent Liabilities | $398.00K |
| Equity | $42.62M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $42.62M |
| Liabilities And Equity | $60.07M |
| Net Cash Flow From Operating Activities | -$57.25M |
| Net Cash Flow From Operating Activities, Continuing | -$57.25M |
| Net Cash Flow From Investing Activities | $36.46M |
| Net Cash Flow From Investing Activities, Continuing | $36.46M |
| Net Cash Flow From Financing Activities | $18.71M |
| Net Cash Flow From Financing Activities, Continuing | $18.71M |
| Exchange Gains/Losses | $405.00K |
| Net Cash Flow | -$1.68M |
| Net Cash Flow, Continuing | -$2.08M |
| Comprehensive Income/Loss | -$64.29M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$64.29M |
| Other Comprehensive Income/Loss | -$51.40M |